PLX313560

GSE156501: Chidamide used in MM primary cells [RNA-seq]

• Organsim human
• Type RNASEQ
• Target gene
• Project ARCHS4

Most patients with multiple myeloma (MM) will eventually relapse and current treatments have limited effect. Herein, we demonstrate that succinate dehydrogenase subunitA (SDHA) was low expressed in MM patients, and patients with SDHA relatively high expression had long overall survival and progression-free survival. Furthermore, SDHA high expression inhibited proliferation and invasion in multiple myeloma (MM) cell lines and enhanced the anti-tumor and synergistic effect of chemotherapeutics. We conducted transcriptome comparison of BMMCs of three MM patients treated with DMSO or chidamide. SOURCE: Yifeng Sun (16111210013@fudan.edu.cn) - Zhongshan Hospital, Fudan University